Lonvita has acquired a 68% stake in Health Italia
The investment vehicle Lonvita S.p.A. has acquired a 68% stake in Health Italia S.p.A. as part of an entrepreneurial project promoted by Giovanni Giuliani and Stefano Pellegrino in the supplementary healthcare sector. The deal includes the launch of a mandatory public offer for the remaining shares of Health Italia, with the objective of delisting the company. Valued at approximately US$70 million, the transaction was structured as a club deal that secured control of Health Italia via Lonvita.
Clessidra Capital Credit SGR, through the Clessidra private debt fund, supported the promoters Giuliani and Pellegrino by providing both equity and mezzanine instruments. Under the new governance structure, Giuliani will assume the role of CEO, while Pellegrino will serve as chairman, guiding the company through its next phase of development.
Founded in 2001, Health Italia has established itself as a benchmark in the supplementary healthcare sector, offering mutualistic solutions, welfare services and telemedicine through a network of more than 8,000 affiliated facilities. The entrepreneurial project, led by Giuliani and Pellegrino, is designed to further enhance the company’s assets and leverage the expertise of Health Italia’s management team, strengthening the distribution platform and expanding the offering through targeted investments in marketing and technology.
Prior to the transaction, Health Italia was controlled by Sorgiva Holding, PFH, Mutua MBA and the founding shareholders, who together held an absolute majority, with the remaining shares owned by public market investors.
Oaklins’ team in Italy acted as the financial advisor to Lonvita in its acquisition of Health Italia. In addition, Oaklins Italy’s parent company, Banca Akros, served as the intermediary responsible for coordinating the collection of acceptances for the mandatory public offer.
Talk to the deal team
Related deals
Instituto Sanitas and Chemopharma have been acquired by Laboratorios Saval
Instituto Sanitas and Chemopharma, leading pharmaceutical laboratories in Chile, have been acquired by Laboratorios Saval S.A., a prominent pharmaceutical company based in Chile with a regional presence across Latin America. The transaction strengthens Laboratorios Saval’s growth strategy and supports its expansion in the affordable medicines segment.
Learn moreDolmans Landscaping Group has welcomed Foreman Capital as a new shareholder to support further growth
Dolmans Landscaping Group, a leading full-service provider of landscaping services, has welcomed Foreman Capital as a new shareholder. By partnering with Foreman Capital, which has extensive experience in building stronger companies in the maintenance of public spaces, Dolmans can accelerate its growth trajectory across core verticals and further professionalize the business.
Learn moreNuzoa has acquired Agrofauna
Nuzoa, a provider of value-added services for pets and livestock in the Iberian Peninsula, has acquired 100% of Agrofauna. This transaction reinforces Nuzoa’s presence in the Portuguese market, particularly in the northern region, marking another step toward its ambition to become the leading operator while further consolidating its brand across Iberia.
Learn more